TEVA director granted 10,863 restricted share units
BARER SOL J reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
BARER SOL J reported acquisition or exercise transactions in this Form 4 filing.
TEVA PHARMACEUTICAL INDUSTRIES LTD director Sol J. Barer received a grant of restricted share units. On May 28, 2026, Barer was awarded 10,863 restricted share units, each representing a contingent right to receive one ordinary share or, at the committee’s option, the cash value of one ordinary share.
The units vest on May 28, 2027, and are reported as a direct holding. Following this grant, Barer holds 10,863 restricted share units linked to the company’s ordinary shares, which may also be represented by American Depositary Shares on a one-for-one basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 10,863 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- F2. Restricted share units were granted on May 28, 2026 and vest on May 28, 2027.
- F3. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Key Figures
Key Terms
contingent right financial
Human Resources and Compensation Committee financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TEVA director Sol J. Barer report on this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.